Tambriza Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 12 years ago on Monday, June 20, 2011, according to the United State Patent & Trademark Office
Word Mark Tambriza
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Methylgene Inc.

View all trademarks for Methylgene Inc.

Previous Owners

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation

Pharmion Corporation of Boulder, CO

View all trademarks for Pharmion Corporation
Other Trademarks for Pharmion Corporation
Serial Number 77266860
Status Date Monday, June 20, 2011
Filing Date Monday, June 20, 2011
Attorney James M. McCarthy

Correspondent

James M. McCarthy
McDonnell Boehnen Hulbert & Berghoff LLP
300 South Wacker Drive
Chicago IL 60606

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, central nervous system, endocrine, gastrointestinal, gynecological, hematological, immunological, hormonal, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological, neurodegenerative and viral related diseases and disorders; pharmaceutical preparations for the treatment of pain, sepsis, diabetes, apopecia, allergies, erectile dysfunction, sexual dysfunction, obesity, and HIV/AIDS

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, September 4, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.